Drew Moghanaki, Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology at UCLA, shared an article by Jochem Kaas on X:

“A new Dutch study demonstrates a clear advantage of SBRT over Surgery for early-stage NSCLC. “

Advantage of SBRT over Surgery for early-stage NSCLC, study by Jochem Kaas

Climate impact of early-stage NSCLC treatment: A comparison between radiotherapy and surgery using Life Cycle Assessment.

Authors: Jochem Kaas, et al.

Advantage of SBRT over Surgery for early-stage NSCLC, study by Jochem Kaas

Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university. He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).